CLEC12A and arthritic joint disease: This regulation is critical for limiting NET-mediated inflammatory conditions, such as in arthritis, SLE or severe COVID-19 infections, in which MICL prevents the formation of a positive-feedback loop that leads to uncontrolled inflammation (Extended Data Fig. 9).